AU2003245995A1 - Use of gaba-c receptor antagonists for the treatment of myopia - Google Patents

Use of gaba-c receptor antagonists for the treatment of myopia

Info

Publication number
AU2003245995A1
AU2003245995A1 AU2003245995A AU2003245995A AU2003245995A1 AU 2003245995 A1 AU2003245995 A1 AU 2003245995A1 AU 2003245995 A AU2003245995 A AU 2003245995A AU 2003245995 A AU2003245995 A AU 2003245995A AU 2003245995 A1 AU2003245995 A1 AU 2003245995A1
Authority
AU
Australia
Prior art keywords
myopia
gaba
treatment
receptor antagonists
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003245995A
Other languages
English (en)
Other versions
AU2003245995A8 (en
Inventor
Wolfgang Frostl
Rudolf Markstein
Katrina L. Schmid
Anne-Ulrike Trendelenburg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003245995A1 publication Critical patent/AU2003245995A1/en
Publication of AU2003245995A8 publication Critical patent/AU2003245995A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003245995A 2002-06-28 2003-06-27 Use of gaba-c receptor antagonists for the treatment of myopia Abandoned AU2003245995A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02014412 2002-06-28
EP02014412.7 2002-06-28
PCT/EP2003/006850 WO2004002399A2 (en) 2002-06-28 2003-06-27 Use of gaba-c receptor antagonists for the treatment of myopia

Publications (2)

Publication Number Publication Date
AU2003245995A1 true AU2003245995A1 (en) 2004-01-19
AU2003245995A8 AU2003245995A8 (en) 2004-01-19

Family

ID=29797147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003245995A Abandoned AU2003245995A1 (en) 2002-06-28 2003-06-27 Use of gaba-c receptor antagonists for the treatment of myopia

Country Status (5)

Country Link
US (1) US20060142249A1 (enExample)
EP (1) EP1526858A2 (enExample)
JP (1) JP2005533082A (enExample)
AU (1) AU2003245995A1 (enExample)
WO (1) WO2004002399A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201808713YA (en) * 2016-04-11 2018-11-29 Univ Canberra Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier
KR102747804B1 (ko) * 2024-03-07 2024-12-31 주식회사 케이에스비튜젠 라세탐 계열 화합물을 유효성분으로 포함하는 눈 기능 장애 예방, 개선 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385939A (en) * 1993-04-30 1995-01-31 The Trustees Of The University Of Pennsylvania GABA-ergic modulation of eye growth
US5627169A (en) * 1994-07-20 1997-05-06 The Regents Of The University Of California Selective antagonists for GABArho receptor
WO1998028313A1 (en) * 1996-12-24 1998-07-02 Novartis Ag (thio)morpholine-substituted carboxylic and phosphinic acids
EP1000071B1 (en) * 1997-06-23 2004-11-17 Polychip Pharmaceuticals Pty. Ltd. Gaba-c receptor antagonists for stimulating memory capacity
US20060264508A1 (en) * 2001-10-16 2006-11-23 Stone Richard A Modulation of ocular growth and myopia by gaba drugs

Also Published As

Publication number Publication date
AU2003245995A8 (en) 2004-01-19
JP2005533082A (ja) 2005-11-04
WO2004002399A3 (en) 2004-04-01
US20060142249A1 (en) 2006-06-29
EP1526858A2 (en) 2005-05-04
WO2004002399A2 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003286567A1 (en) Methods for the treatment of skin disorders
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
AU2003217275A1 (en) Azabicyclic compounds for the treatment of disease
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2003267088A1 (en) Chemokine receptor antagonists as therapeutic agents
AU2003279841A1 (en) Uses of human zven antagonists
AU2003300904A1 (en) Antagonists for human prolactin
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003236649A1 (en) Egf receptor antagonists in the treatment of gastric cancer
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
AU2003259074A1 (en) Gal3 antagonists for the treatment of neuropathic pain
AU2003245995A1 (en) Use of gaba-c receptor antagonists for the treatment of myopia
AU2003273856A1 (en) Vr1 antagonists for the treatment of urological disorders
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
AU6523200A (en) Vitronectin receptor antagonists useful for the treatment of strokes
AU6991300A (en) Use of 5-ht3 receptor antagonists for the treatment of inflammations of the respiratory tract
AU2003281836A1 (en) Implant for the treatment of presbyopia
AU2003300867A1 (en) Uses of the snorf207 receptor
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase